knowcompoundssynephrine
Specimen compoundPlate I
Synephrine

- ChEBI
- CHEBI:29081
- PubChem CID
- 7172
↑ raised 2 findings in 2 endpoints · – no difference found 2 in 2
01 · the evidence, ordered
What the evidence says
- Strong
- 0
- Moderate
- 0
- Limited
- 1
- Very limited
- 3
- Insufficient
- 0
Synephrine
Most findings
- Maximal fat oxidation rate (MFO)×2
- Whole-body fat oxidation rate×2
1 compound on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
02 · contested · 2 endpoints
Where the findings disagree
012 findings
Maximal fat oxidation rate (MFO)
022 findings
Whole-body fat oxidation rate
03 · findings
What synephrine moved, and by how much
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
4 shown
- Maximal fat oxidation rate (MFO)contestedMoved: no difference foundEvidence: LimitedPaper: PMID 362970362022
- Who
- 18 healthy, recreationally active women, fasted, morning trials, one acute dose against a cellulose placebo in a randomised crossover; MFO taken from a ramp test on a cycle ergometer in 3-minute stages from 30% to 80% of VO2max
- Dose studied
- 3 mg p-synephrine per kg body mass as synephrine HCl, single oral dose 60 min before the exercise test
The intake of p-synephrine did not modify MFO (0.28 ± 0.08 vs. 0.26 ± 0.10 g/min, p = 0.449, d = 0.21, respectively) or Fatmax (44.6 ± 7.8 vs. 40.8 ± 8.6%, p = 0.096, d = 0.50, respectively) over the placebo condition.”
Quoted verbatim from Effect of p-Synephrine on Fat Oxidation Rate during Exercise of Increasing Intensity in Healthy Active Women.crossoverPermalink - Whole-body fat oxidation ratecontestedMoved: raisesEvidence: Very limitedPaper: PMID 316910182020
- Who
- 14 healthy subjects; total fat oxidised in grams over 1 h of continuous cycling at Fatmax (the intensity of maximal fat oxidation rate); one acute dose against a cellulose placebo in a double-blind, randomised two-trial design
- Dose studied
- 3 mg/kg p-synephrine, single oral dose
However, p-synephrine increased whole-body fat oxidation (33.6 ± 10.4 vs. 37.3 ± 9.8 g, P < 0.01) while also reducing carbohydrate oxidation (99.5 ± 30.4 vs. 85.0 ± 28.4 g, P < 0.01).”
Quoted verbatim from Acute p-synephrine ingestion increases whole-body fat oxidation during 1-h of cycling at Fatmax.crossoverPermalink - Whole-body fat oxidation ratecontestedMoved: no difference foundEvidence: Very limitedPaper: PMID 270382252016
- Who
- 18 healthy subjects, at rest, one acute dose against a cellulose placebo in a double-blind, randomised, counterbalanced two-trial design
- Dose studied
- 3 mg/kg p-synephrine, single oral dose
In comparison with the placebo, the ingestion of p-synephrine did not change energy consumption (1.6 ± 0.3 vs. 1.6 ± 0.3 kcal min(-1) ; P = 0.69) or fat oxidation rate at rest (0.08 ± 0.02 vs. 0.10 ± 0.04 g min(-1) ; P = 0.15).”
Quoted verbatim from Acute p-synephrine ingestion increases fat oxidation rate during exercise.crossoverPermalink - Maximal fat oxidation rate (MFO)contestedMoved: raisesEvidence: Very limitedPaper: PMID 270382252016
- Who
- 18 healthy subjects, during a cycle ergometer ramp test to volitional fatigue (25 W every 3 min), one acute dose against a cellulose placebo in a double-blind, randomised, counterbalanced two-trial design
- Dose studied
- 3 mg/kg p-synephrine, single oral dose
Moreover, p-synephrine increased maximal fat oxidation rate (0.29 ± 0.15 vs. 0.40 ± 0.18 g min(-1) ; P = 0.01) during exercise although it did not affect the intensity at which maximal fat oxidation was achieved (55.8 ± 7.7 vs. 56.7 ± 8.2% VO2peak ; P = 0.51).”
Quoted verbatim from Acute p-synephrine ingestion increases fat oxidation rate during exercise.crossoverPermalink
No row matches these filters.
No dose is advised.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
04 · on the label · 200 products
Labelled products
Source: NIH DSLD · Ingredient: synephrine · 200 products · Declared amount per serving: 4.5–100 mg
108 labels state an amount92 do not
- 'Merica LabzF-Bomb Cat Scratch Fever30 mgper 7.55 gDSLD:316263
- 'Merica LabzF-Bomb F Your Feelings30 mgper 8.7 gDSLD:316265
- 'Merica LabzF-Bomb Firecracker Candy50 mgper 8.5 gDSLD:278031
- 'Merica LabzF-Bomb Fruit Cocktail30 mgper 8 gDSLD:316264
- 'Merica LabzF-Bomb Sour Pucker UP Buttercup30 mgper 8.75 gDSLD:327302
- 'Merica LabzF-Bomb Upside Down Pineapple30 mgper 7.75 gDSLD:316266
- 1 Up NutritionHer Pro Pump Blue Raspberryamount not statedper 9 gDSLD:64815
- 1 Up NutritionHer Pro Pump Fruit Punchamount not statedper 4.5 gDSLD:64822
- 1 Up NutritionHer Pro Pump Key Lime Iceamount not statedper 4.5 gDSLD:64823
- 1 Up NutritionPro Pump Blue Raspberryamount not statedper 6 gDSLD:64860
- 1 Up NutritionPro Pump Fruit Punchamount not statedper 6 gDSLD:64864
- 1 Up NutritionPro Pump Key Lime Iceamount not statedper 6 gDSLD:64865
Show the remaining 188Show the first 12
Label record: NIH Office of Dietary Supplements · CC0
05 · the record
Sources
68
papers screened for synephrine
- admitted
- 3
- read and discarded
- 21
- not read yet
- 44
- Documented interactions
- None reported
Sources cited
3 papers · 4 findings